Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11421
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMount, Peter F-
dc.contributor.authorGleich, Kurt-
dc.contributor.authorTam, Shanna-
dc.contributor.authorFraser, Scott A-
dc.contributor.authorChoy, Suet-Wan-
dc.contributor.authorDwyer, Karen M-
dc.contributor.authorLu, Bo-
dc.contributor.authorDenderen, Bryce Van-
dc.contributor.authorFingerle-Rowson, Günter-
dc.contributor.authorBucala, Richard-
dc.contributor.authorKemp, Bruce E-
dc.contributor.authorPower, David Anthony-
dc.date.accessioned2015-05-16T01:01:38Z
dc.date.available2015-05-16T01:01:38Z
dc.date.issued2012-01-09-
dc.identifier.citationPLoS One 2012; 7(1): e29887en_US
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/11421en
dc.description.abstractActivation of the master energy-regulator AMP-activated protein kinase (AMPK) in the heart reduces the severity of ischemia-reperfusion injury (IRI) but the role of AMPK in renal IRI is not known. The aim of this study was to determine whether activation of AMPK by acute renal ischemia influences the severity of renal IRI.AMPK expression and activation and the severity of renal IRI was studied in mice lacking the AMPK β1 subunit and compared to wild type (WT) mice.Basal expression of activated AMPK, phosphorylayed at αThr¹⁷², was markedly reduced by 96% in AMPK-β1⁻/⁻ mice. Acute renal ischaemia caused a 3.2-fold increase in α1-AMPK activity and a 2.5-fold increase in α2-AMPK activity (P<0.001) that was associated with an increase in AMPK phosphorylation of the AMPK-α subunit at Thr¹⁷² and Ser⁴⁸⁵, and increased inhibitory phosphorylation of the AMPK substrate acetyl-CoA carboxylase. After acute renal ischemia AMPK activity was reduced by 66% in AMPK-β1⁻/⁻ mice compared with WT. There was no difference, however, in the severity of renal IRI at 24-hours between AMPK-β1⁻/⁻ and WT mice, as measured by serum urea and creatinine and histological injury score. In the heart, macrophage migration inhibitory factor (MIF) released during IRI contributes to AMPK activation and protects from injury. In the kidney, however, no difference in AMPK activation by acute ischemia was observed between MIF⁻/⁻ and WT mice. Compared with the heart, expression of the MIF receptor CD74 was found to be reduced in the kidney.The failure of AMPK activation to influence the outcome of IRI in the kidney contrasts with what is reported in the heart. This difference might be due to a lack of effect of MIF on AMPK activation and lower CD74 expression in the kidney.en_US
dc.language.isoenen
dc.subject.otherAMP-Activated Protein Kinases.deficiency.metabolismen
dc.subject.otherAnimalsen
dc.subject.otherCreatinine.blooden
dc.subject.otherEnzyme Activationen
dc.subject.otherKidney.blood supply.enzymology.pathologyen
dc.subject.otherMacrophage Migration-Inhibitory Factors.deficiency.metabolismen
dc.subject.otherMiceen
dc.subject.otherPhosphorylationen
dc.subject.otherReperfusion Injury.blood.enzymology.pathologyen
dc.subject.otherUrea.blooden
dc.titleThe outcome of renal ischemia-reperfusion injury is unchanged in AMPK-β1 deficient mice.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitlePLoS Oneen_US
dc.identifier.affiliationNephrologyen_US
dc.identifier.doi10.1371/journal.pone.0029887en_US
dc.description.pagese29887en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/22253816en
dc.type.contentTexten_US
dc.type.austinJournal Articleen
local.name.researcherChoy, Suet-Wan
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.languageiso639-1en-
crisitem.author.deptNephrology-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptNephrology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

24
checked on Mar 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.